← Back to Clinical Trials
Recruiting NCT07005674

NCT07005674 Cycle Nation Communities: Increasing Cycling in Glasgow

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07005674
Status Recruiting
Phase —
Sponsor University of Glasgow
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 268 participants
Start Date 2025-05-27
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Cycle NationCycling Scotland standard cycling session

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 268 participants in total. It began in 2025-05-27 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomised controlled trial will evaluate the effects of a 9-week multi-component group-based cycling programme (Cycle Nation) versus a standard single cycle training session on self-reported cycling, health and wellbeing outcomes. Participants are adults that do not regularly cycle, who will be randomly allocated to each arm of the study. Outcomes will be assessed at baseline, post-programme, and at 12 months from baseline. Cost effectiveness will be assessed, and a process evaluation will be conducted.

Eligibility Criteria

Inclusion Criteria: Can ride a bicycle Self-identified infrequent cyclists (currently cycle less than once per month) Aged 18 years or over Willing to provide informed consent Willing to partake in measurements Willing to be randomised to intervention or control arm Have a good understanding of the English language Not have a contraindication to moderate intensity physical activity as assessed by the adapted Physical Activity Readiness Questionnaire-Plus (PAR-Q+) Able to attend in-person sessions (at least 6 out of 9 sessions) Intend to still be in the UK by November 2026 Exclusion Criteria: Cannot cycle (i.e. cannot balance and/or have never learnt to cycle) Frequent or regular cyclists (i.e. currently cycle at least once a month, confident riding on roads) Less than 18 years old Not willing to provide informed consent Not willing to partake in measurements Not willing to be randomised to the intervention or control arm Cannot speak basic English Have a contraindication to moderate intensity physical activity as assessed by the adapted Physical Activity Readiness Questionnaire-Plus (PAR-Q+) Not able to attend in-person sessions (less than 6 out of 9 sessions) Not intending to still be in the UK by November 2026

Contact & Investigator

Central Contact

Fernanda Gabler Trisotti, PhD

✉ gallanttravel@glasgow.ac.uk

📞 07886700868

Principal Investigator

Jason Gill, PhD

PRINCIPAL INVESTIGATOR

University of Glasgow

Frequently Asked Questions

Who can join the NCT07005674 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07005674 currently recruiting?

Yes, NCT07005674 is actively recruiting participants. Contact the research team at gallanttravel@glasgow.ac.uk for enrollment information.

Where is the NCT07005674 trial being conducted?

This trial is being conducted at Glasgow, United Kingdom.

Who is sponsoring the NCT07005674 clinical trial?

NCT07005674 is sponsored by University of Glasgow. The principal investigator is Jason Gill, PhD at University of Glasgow. The trial plans to enroll 268 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology